SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Net sales declined -11.64%  to  Rs. 114.67 million from Rs. 129.77 millions.The Net Loss for the quarter ended December 2024 is Rs. -77.39 millions as compared to Net Loss of Rs. -49.78 millions of corresponding quarter ended December 2023 Operating profit Margin for the quarter ended December 2024 further decreased to -44.65% as compared to -20.61% of corresponding quarter ended December 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 114.67 129.77 -11.64 372.11 384.48 -3.22 504.22 521.34 -3.28
Other Income 2.51 0.29 765.52 3.71 2.41 53.94 4.51 6.20 -27.26
PBIDT -44.65 -20.61 116.64 -92.52 -53.70 72.29 -82.72 -151.59 -45.43
Interest 15.57 11.86 31.28 43.00 34.17 25.84 46.89 29.73 57.72
PBDT -60.22 -32.47 85.46 -135.52 -87.87 54.23 -129.61 -181.32 -28.52
Depreciation 17.17 17.31 -0.81 51.19 50.95 0.47 67.66 65.59 3.16
PBT -77.39 -49.78 55.46 -186.71 -138.82 34.50 -197.27 -246.91 -20.10
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -77.39 -49.78 55.46 -186.71 -138.82 34.50 -197.27 -246.91 -20.10
Equity 215.61 215.61 0.00 215.61 215.61 0.00 215.61 215.61 0.00
PBIDTM(%) -38.94 -15.88 145.17 -24.86 -13.97 78.02 -16.41 -29.08 -43.58

Krebs Biochem.&Inds Share Price

60.90 -0.12 (-0.20%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×